Lineage Cell Therapeutics (LCTX)
(Delayed Data from AMEX)
$0.95 USD
+0.06 (6.28%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $0.95 0.00 (0.20%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.04 | 12.50% |
Earnings Summary
For their last quarter, Lineage Cell Therapeutics (LCTX) reported earnings of -$0.03 per share, beating the Zacks Consensus Estimate of $-0.04 per share. This reflects a positive earnings surprise of 25.00%. Look out for LCTX's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.04 per share, reflecting no change in earnings compared to the year-ago quarter.
Earnings History
Price & Consensus
Zacks News for LCTX
Beam Therapeutics Inc. (BEAM) Reports Q2 Loss, Misses Revenue Estimates
LCTX: What are Zacks experts saying now?
Zacks Private Portfolio Services